Epitalon is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) that activates telomerase and restores pineal melatonin production
CLA is a versatile supplement that offers a unique combination of fat loss and muscle preservation benefits

Consequently, companies such as Novo Nordisk and Eli Lilly are investing heavily in next-generation formulations, including oral small-molecule GLP-1 receptor agonists such as orforglipron, which aim to expand patient accessibility and therapeutic scope The demand for GLP-1 drugs that address a wider array of metabolic conditions is growing rapidly across global markets, as patients and healthcare providers increasingly seek holistic and effective long-term treatment options for obesity and its comorbidities GLP-1 Receptor Agonists Obesity Drugs Market Dynamics Driver Surging Demand Due to Rising Obesity Prevalence and Enhanced Clinical Outcomes The global surge in obesity rates and associated comorbidities such as type 2 diabetes and cardiovascular diseases is significantly driving demand for GLP-1 receptor agonist drugs as effective medical weight loss therapies For instance, in May 2024, Novo Nordisk announced a USD 4.1 billion expansion in its U.S

[DOI] [PMC free article] [PubMed] [Google Scholar] 185.Borsoi F.T., Neri-Numa I.A., de Oliveira W.Q., de Arajo F.F., Pastore G.M
Kipp, Selenium, zinc, and copper status of vegetarians and vegans in comparison to omnivores in the nutritional evaluation (NuEva) study